DexCom Inc (DXCM)

Cash conversion cycle

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Days of inventory on hand (DOH) days 124.04 141.25 141.96 152.11 153.18 148.03 133.29 124.28 109.03 116.02 136.73 149.12 169.81 180.04 174.10 160.43 132.49 116.22 97.44 89.08
Days of sales outstanding (DSO) days
Number of days of payables days
Cash conversion cycle days 124.04 141.25 141.96 152.11 153.18 148.03 133.29 124.28 109.03 116.02 136.73 149.12 169.81 180.04 174.10 160.43 132.49 116.22 97.44 89.08

December 31, 2024 calculation

Cash conversion cycle = DOH + DSO – Number of days of payables
= 124.04 + — – —
= 124.04

The cash conversion cycle measures how long it takes for a company to convert its investments in inventory and other resources into cash flows from sales. For DexCom Inc, the cash conversion cycle has fluctuated over the years, starting at 89.08 days as of March 31, 2020, and reaching a peak of 180.04 days as of September 30, 2021. Since then, the trend has been declining, with the cycle standing at 124.04 days as of December 31, 2024.

A shorter cash conversion cycle is generally favorable as it indicates that the company is efficient in managing its working capital and generating cash from its operations. DexCom Inc experienced a notable improvement in its cash conversion cycle in recent periods, which suggests that the company has become more efficient in managing its inventory, receivables, and payables.

Analyzing the trend in the cash conversion cycle can provide insights into DexCom Inc's operational efficiency and liquidity management. It is important for investors and stakeholders to monitor this metric to assess how effectively the company is utilizing its resources to generate cash and support its business operations.


See also:

DexCom Inc Cash Conversion Cycle (Quarterly Data)